Shandong Luoxin Pharmacy Group Co Ltd operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Shandong Luoxin Pharmacy Group Co Ltd with three other
companies in this sector in China:
Tianjin Chase Sun Pharmaceutical Company Limited
sales of 3.87 billion Chinese Renmimbi [US$561.41 million]
of which 49%
Zhejiang Huahai Pharmaceutical
(4.09 billion Chinese Renmimbi [US$594.19 million]
of which 48%
was Drug Sale), and
Shenzhen Salubris Pharmaceuticals Co Ltd
(3.83 billion Chinese Renmimbi [US$556.55 million]
of which 100%
was Pharmaceutical Manufacturing).
During the year ended December of 2016, sales at
Shandong Luoxin Pharmacy Group Co Ltd were 4.12 billion Chinese Renmimbi (US$597.79 million).
increase of 14.0%
versus 2015, when the company's sales were 3.61 billion Chinese Renmimbi.
This was the fifth consecutive year of sales increases at Shandong Luoxin Pharmacy Group Co Ltd
(and since 2011, sales have increased a total of 153%).